|
111
|
270
|
5u3rA |
Human ppardelta ligand-binding domain in complexed with specific agonist 2 |
|
105
|
269
|
5u3yA |
Human ppardelta ligand-binding domain in complexed with specific agonist 9 |
|
109
|
268
|
5u3zA |
Human ppardelta ligand-binding domain in complexed with specific agonist 10 |
|
101
|
266
|
5u41A |
Human ppardelta ligand-binding domain in complexed with specific agonist 16 |
|
90
|
249
|
5u2dA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with oxabicyclic heptene sulfonate (obhs) |
|
108
|
270
|
5u43A |
Human ppardelta ligand-binding domain in complexed with specific agonist 12 |
|
108
|
271
|
5u3tA |
Human ppardelta ligand-binding domain in complexed with specific agonist 4 |
|
102
|
268
|
5u3uA |
Human ppardelta ligand-binding domain in complexed with specific agonist 5 |
|
87
|
250
|
5u2bA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the phenylamino-substituted estrogen, (8r,9s,13s,14s,17s)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide |
|
104
|
270
|
5u46A |
Human ppardelta ligand-binding domain in complexed with gw501516 |
|
109
|
271
|
5u42A |
Human ppardelta ligand-binding domain in complexed with specific agonist 11 |
|
106
|
271
|
5u3wA |
Human ppardelta ligand-binding domain in complexed with specific agonist 7 |
|
78
|
243
|
5tlmA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 4,4',4''-(thiophene-2,3,5-triyl)triphenol |
|
89
|
244
|
5tmsA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the cyclofenil-asc derivative, ethyl (e)-3-(4-(bicyclo[3.3.1]nonan-9-ylidene(4-hydroxyphenyl)methyl)phenyl)acrylate |
|
84
|
244
|
5tm4A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc analog, 5-(4-((1r,4s,6r)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)pentanoic acid |
|
81
|
244
|
5tlgA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with (e)-4,4''-dihydroxy-3'-((hydroxyiminio)methyl)-[1,1':2',1''-terphenyl]-4'-olate |
|
92
|
247
|
5tmwA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs derivative, 4-acetamidophenyl (1s,2r,4s)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate |
|
85
|
244
|
5tmqA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the arene core obhs derivative, 4-bromophenyl 4,4''-dihydroxy-[1,1':2',1''-terphenyl]-4'-sulfonate |
|
82
|
244
|
5tllA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with (e)-2-chloro-4'-hydroxy-4-((hydroxyiminio)methyl)-[1,1'-biphenyl]-3-olate |
|
87
|
245
|
5tm6A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc compound, 6-(4-((1r,4s,6r)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)hexanoic acid |
|
89
|
244
|
5tn6A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the spiro bc-estradiol, (1s,1's,3a's,7a's)-7a'-methyl-1',2,2',3,3',3a',4',6',7',7a'-decahydro-1,5'-spirobi[indene]-1',5-diol |
|
82
|
247
|
5tm7A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc compound, 7-(4-((1r,4s,6r)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid |
|
87
|
245
|
5tmrA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the cyclofenil-asc derivative, ethyl (e)-3-(4-(cyclohexylidene(4-hydroxyphenyl)methyl)phenyl)acrylate |
|
86
|
244
|
5tmtA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 4,4'-((1,3-dihydro-2h-inden-2-ylidene)methylene)diphenol |
|
78
|
243
|
5tmmA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc analog, (e)-6-(4-((1r,4s,6r)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)hex-5-enoic acid |
|
88
|
245
|
5tmzA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the estradiol derivative, (8s,9s,13s,14s,17s)-16-(3-methoxybenzyl)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthrene-3,17-diol |
|
81
|
243
|
5tloA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with a squaric acid-linked dimeric estrogen |
|
90
|
245
|
5tmoA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the arene core obhs derivative, phenyl 4,4''-dihydroxy-[1,1':2',1''-terphenyl]-4'-sulfonate |
|
89
|
244
|
5tldA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the phenylamino-substituted estrogen, (8r,9s,13s,14s,17s)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-ol |
|
90
|
244
|
5tn4A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the acd-ring estrogen, (s)-5-(4-hydroxy-3,5-dimethylphenyl)-2,3-dihydro-1h-inden-1-ol |
|
94
|
244
|
5tm3A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 2,3-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide |
|
91
|
246
|
5tn3A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the estradiol derivative, (8s,9s,13s,14s)-17-((4-isopropylphenyl)amino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-ol |
|
75
|
241
|
5tm2A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 2,5-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide |
|
91
|
245
|
5tn5A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the ac-ring estrogen, (1s,3as,5s,7as)-5-(4-hydroxyphenyl)-7a-methyloctahydro-1h-inden-1-ol |
|
93
|
244
|
5tm5A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc compound, 5-(4-((1r,4s,6r)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)pentanoic acid |
|
88
|
244
|
5tn8A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with (e)-4'-hydroxy-3-((hydroxyiminio)methyl)-[1,1'-biphenyl]-4-olate |
|
90
|
248
|
5tn1A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the estradiol derivative, (8s,9s,13s,14s,e)-17-((4-isopropylphenyl)imino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthren-3-ol |
|
109
|
270
|
5twoA |
Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selectively ppar gamma-modulating ligand vsp-51 |
|
80
|
241
|
5tn9A |
Crystal structure of the er-alpha ligand-binding domain (l372s,l536s) in complex with the obhs-bsc, 4-bromophenyl (1r,2r,4s)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate |
|
85
|
241
|
5tnbA |
Crystal structure of the er-alpha ligand-binding domain (l372s,l536s) in complex with the obhs-bsc, 4-bromophenyl (1r,2r,4s)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate |
|
88
|
244
|
5tluA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the peg-linked dimeric estrogen, ee2-(eg)6-ee2-amine |
|
92
|
245
|
5tlvA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 4,4'-(thiophene-2,3-diyl)bis(3-fluorophenol) |
|
86
|
244
|
5tm8A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc compound, 7-(4-((1r,4s,6r)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid |
|
93
|
271
|
5ttoA |
X-ray crystal structure of ppargamma in complex with sr1643 |
|
77
|
223
|
5tm9A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc analog, (e)-3-(4-((1r,4s,6r)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)acrylic acid |
|
91
|
244
|
5tn7A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with (e)-3'-fluoro-4'-hydroxy-3-((hydroxyiminio)methyl)-[1,1'-biphenyl]-4-olate |
|
88
|
244
|
5tlxA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with 3,4-bis(4-hydroxyphenyl)thiophene 1,1-dioxide |
|
89
|
240
|
5toaA |
Crystal structure of er beta bound to estradiol |
|
90
|
249
|
5tmlA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the obhs-asc compound, (e)-6-(4-((1r,4s,6r)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)hex-5-enoic acid |
|
93
|
245
|
5tlfA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the constrained way derivative, 4-(2-(3-methylbut-2-en-1-yl)-7-(trifluoromethyl)-2h-indazol-3-yl)benzene-1,3-diol |
